Do you have T-cell Lymphoma? Is your disease relapsed or refractory and CD5 positive? If so, you may be able to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.
Are you pregnant? Are you planning a scheduled cesarean delivery? If so, you may be able to take part in a study to see if using two antibiotics before a C-section instead of just one can lower the risk of infections. The infections we want to prevent are womb infection, wound infection, or a serious blood infection. Compensation provided.
Do you have incurable, metastatic/recurrent head and neck squamous cell carcinoma? If so, you may be able to take part in a study to see if a new drug called petosemtamab is effective. We want to see if petosemtamab works better than the treatments doctors usually use for head and neck squamous cell carcinoma. Compensation provided.
Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.
Have you been diagnosed with Stage III non-small cell lung cancer? Is your cancer advanced and not able to to removed? If so, you might be able to participate in a study that looks at a study drug to see if it can help the radiation treatment work better against your cancer.
This is a research study for pediatric patients previously been diagnosed with generalized myasthenia gravis (gMG) which is a condition that causes abnormalities of your immune system which may lead to generalized muscle weakness. This study looks at an investigational drug called ravulizumab (referred to as "study drug") to treat gMG by blocking complement activity that fights against infections. Although ravulizumab is approved to treat gMG in adults, in this study, ravulizumab is considered an experimental drug, which means it is not approved for use in treating children with gMG in any country at this time.
Help us advance research for cerebellum disorders! The ARC Study (Advancing Research for Cerebellum Disorders using 3T & 7T MRI) is currently looking for healthy participants to participate in a research study involving brain MRI scans. Participants can earn up to $100 in giftcards for participation.
Are you a breast cancer survivor? if soy you may be eligible to participate in this research study that is looking at the effectiveness of fisetin and/or exercise on physical function assessed using a 6 minute walking distance in chemotherapy-treated postmenopausal breast cancer survivors
If you have liver cirrhosis or chronic hepatitis B infection, you may qualify to participate in a research study that compares the effectiveness of two liver cancer screening methods. Please contact the study team to get more information. Compensation provided.
Do you have BRCA1 mutation and have elected to undergo a surgical intervention? If so, you may be able to take part in a research study comparing two surgical procedures and their ability to decrease the risk of developing ovarian cancer.